SEC Filing Details

Together with patients, physicians, scientists, and industry partners we are relentlessly focused on rewriting cancer so that a diagnosis is transformed from a foregone conclusion to a more hopeful future

SEC Filing Details

Document Details

Filing Date
Apr 3, 2020
Document Date
May 14, 2020
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.